Clinical Trials

A Phase 3 Study to Evaluate Zimberelimab (AB122) Monotherapy Compared to Standard Chemotherapy or Zimberelimab Combined with AB154 in Front-Line, PD-L1-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Principal Investigator: Dr. Zhahirul Islam, PhD Principal Investigator (icddr,b) ARC-10 study Scientist, Laboratory Sciences and Services Division icddr,b. Phone no. +8801710957036 Email: zislam@icddrb.org

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 28 Nov, 2021

A double blinded phase I clinical trial to investigate the safety and immunogenicity of an mRNA-based vaccine (GBPDO6O) against SARS-CoV-2 in healthy adult volunteers

Principal Investigator: Professor Dr. Mamun Al Mahtab Principal Investigator for the clinical trial of GBPDO60 Head of Interventional Hepatology Division Bangabandhu Sheikh Mujib Medical University Shahbag, Dhaka-1000 Mobile: 01711567275 e-mail: shwapnil@agni.com

CRO: M/S Bangabandhu Sheik Mujib Medical University (BSMMU) Shahabag Dhaka-1000.

Application Date: 25 Nov, 2021

9 A Phase-III, double blind, randomized active controlled study to evaluate safety and immunogenicity of inactivated adjuvanted. Polio vaccine in comparison with licensed Inactivated Poliovirus vaccines

Principal Investigator: Dr. K Zaman Senior Scientist and Principal Investigator Influenza vaccine study Infectious Diseases Division (IDD)icddr, b

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 30 Oct, 2021

Assessing immunogenicity of intramuscular Sabin inactivated poliovirus vaccine and non-inferiority of intradermal fractional inactivated poliovirus vaccine.

Principal Investigator: Dr. K Zaman Senior Scientist and Principal Investigator Influenza vaccine study Infectious Diseases Division (IDD) icddr, b 68 Shaheed tajuddin ahmed soroni Mohakhali, Dhaka1212 Mobile: 01713047100 E-Mail: kzaman@icddrb.org

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 3 Oct, 2021

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomized non-inferiority trial.

Principal Investigator: Dr. Sharika Nuzhat, Assistant Scientist and Principal Investigator, Nutrition and clinical services division, icddr,b

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 15 Sep, 2021

Efficacy & demonstration of Intravenous Iron for Anemia in Pregnancy

Principal Investigator: Dr. Jena Derakhshani Hamadani Emeritus Scientist Material & Child Health Division, icddr,b

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 5 Sep, 2021

Effects of Oral Intake of olive leaf Extract on hematological parameters: Phase-I, A Double-blinded Randomized, Placebo-controlled study among young adults in Bangladesh.

Principal Investigator: Dr. Masud Alam. MDDS, MPH, Division, icddr,b

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 22 Aug, 2021

Approval of a protocol entitled "A multi - center randomized controlled non-inferiority trial to compare the efficacy safety & triple artemidinin based combination the rapies versus first-line ACTs + placebo for the treatment of uncomplicated plasmodium falciparum malaria in Asia

Principal Investigator: Professor Md. Abul Faiz, Professor of Medicines (Retired), Former Director General of Health Services, Dhaka, Bangladesh.

CRO: M/S Dev Care Foundation

Application Date: 18 Aug, 2021

A Phase-III, Randomized double-blind, placebocontrolled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal Vaccine, administrated IM to pregnant woman 18 to 49 year of age, for prevention of RSV associated LRTI in their infants up to 6 months of age

Principal Investigator: Dr. K Zaman Senior Scientist and Principal Investigator Influenza vaccine study Infectious Diseases Division (IDD)icddr, b 68 Shaheed tajuddin ahmed soroni Mohakhali, Dhaka1212 Mobile: 01713047100 E-Mail: kzaman@icddrb.org

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 11 Aug, 2021

The role of the Gut microbiome in shaping immune response to the oral cholera vaccine euvichol.

Principal Investigator: Dr. Jasmin Akter, Infectious Diseases Division (IDD), icddr,b, Mohakhali, Dhaka-1212.

CRO: International Centre for Diarrhoeal Disease Research Bangladesh (icddr,b).

Application Date: 4 Aug, 2021

Showing 51 to 60 of 65 results